SpassMed scores US FDA 510(k) for AI sepsis detection softwareSouth Korean medical AI company SpassMed has received the United States Food and Drug Administration’s 510(k) clearance for its AI-powered sepsis detection software.
The AI solution…
By Shania Kennedy
June 22, 2023 – Researchers evaluating an artificial intelligence (AI) model’s ability to estimate prostate cancer extent and define focal treatment margins for tumors demonstrated that the model outperformed conventional methods, according to…
Continue Reading
Blue Earth Diagnostics and PETNET Solutions, a Siemens Healthineers Company, have announced the availability of POSLUMA (Flotufolastat F 18) Injection for PET Imaging of Prostate Cancer in the United States. POSLUMA, an optimized PET…
Continue Reading
Carrum Health, a digital marketplace for employers to purchase bundled healthcare services, announced its Center of Excellence network will be integrated into healthcare navigation platform apree health’s partner network for employees to access affordable…
Continue Reading
What You Should Know:
Mindpeak, a leading provider of artificial intelligence (AI) for pathology, and Proscia®, a leading provider of digital and computational pathology solutions, have announced a partnership to broaden access to improved diagnosis for cancer…
Continue Reading
Teledermatology is playing a key role in the fight against skin cancer, with the NHS recently announcing that it will invest in and accelerate the rollout of it to use within the urgent two-week-wait…
Continue Reading
Millions of women worldwide are affected by breast cancer, a prevalent form of cancer. For approximately 8 out of 10 cases, invasive ductal carcinoma (IDC) is the most prevalent form of breast cancer. IDC…
Continue Reading
By Shania Kennedy
June 19, 2023 – Researchers have shown that omitting race and ethnicity as predictors in colorectal cancer recurrence risk prediction models may be associated with racial and ethnic biases that contribute to health…
Continue Reading
By Sarai Rodriguez
June 19, 2023 – Urban neighborhoods, once redlined by federal officials in the 1930s, are still haunted by the effects, as new research shows they face cancer screening disparities.
Individuals residing in historically redlined…
Continue Reading
IBA, a world leader in particle accelerator technology and proton therapy, has partnered with PARTICLE to develop ConformalFLASH, an innovative cancer treatment technique. Through this collaboration, IBA will integrate FLASH therapy into PARTICLE’s clinical…
Continue Reading
